07 Jan 2001

Vivural® 500 (Vivural® 500/-1000 Brausetabletten) - Deutschland

Updated: 07 Jan 2001

Vivural® 500 | -1000

Therapie des Calciummangels bei Tetanie und Osteoporose; Prophylaxe bei erhöhtem Calciumbedarf in der Schwangerschaft und während der Stillzeit sowie im Wachstumsalter.

Vivural® 500 Description, Presentation and Dosage

Vivural® 500 Description

Vivural® 500 Drug Class Description

Andere Einzelstoffe

Vivural® 500 Drug Description

1 Brausetbl. enth.: Calciumcarbonat 1,25 g/2,5 g (entspr. 500 mg/1000 mg Calcium).

Vivural® 500 Generic Name

Vivural® 500/-1000 Brausetabletten

Vivural® 500 Presentation

Vivural® 500 Presentation

Vivural® 500/-1000

Vivural® 500 Manufacturer

Procter & Gamble Pharmaceuticals

Related Learning Zones

Hypogonadism Knowledge Centre

Hypogonadism Knowledge Centre

The Hypogonadism Knowledge Centre provides healthcare professionals with free access to disease awareness sections such as epidemiology, pathophysiology, signs and symptoms, treatment options to assist the process of diagnosis, treatment and monitoring of patients with the condition. The regularly updated publications digest area contains analysis and comment on recent scientific articles related to male hypogonadism.

G.MKT.GM.MH.01.2016.0364

IL-17A in Psoriasis Knowledge Centre

IL-17A in Psoriasis Knowledge Centre

IL-17A in Psoriasis is intended for healthcare professionals involved in the treatment and management of patients with psoriasis. This resource has been developed primarily to discuss the role of the IL-17 pathway in the pathogenesis of psoriasis and the therapeutic potential of treatments directed towards IL-17A. Users can expect to find sections containing expert videos, clinical slide decks, congress highlights, key publications and links to useful resources.

This resource has been developed in collaboration with Novartis Pharma AG.

Vivural® 500 Dosage

Vivural® 500 Adult Dosage

Citronensäure H2O-frei, Natriumcyclamat, Saccharin-Natrium 2H2O, Farbstoff E 110, Aromastoff.

Vivural® 500 Precautions, Reactions and Contraindications

Vivural® 500 Special Precautions

Vivural® 500 Special Precautions

C 8 a-c. Chron. Harnwegsinfekte mit harnstoffspaltenden Bakterien (Gefahr einer Struvitsteinbildung).

Vivural® 500 Adverse Reactions

Vivural® 500 Adverse Reactions

C 8

Related Drugs - Rheumatology

Back to top